Oncology Product Guide » FORTIS-M http://www.oncologyproductguide.com/blog A comprehensive guide to oncology products for medical professionals Fri, 11 Jun 2010 12:00:01 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 Agennix Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally http://www.oncologyproductguide.com/blog/2010/01/21/agennix-expands-talactoferrin-phase-3-fortis-m-registration-trial-globally/ http://www.oncologyproductguide.com/blog/2010/01/21/agennix-expands-talactoferrin-phase-3-fortis-m-registration-trial-globally/#comments Fri, 22 Jan 2010 04:19:42 +0000 Jim Marino http://www.oncologyproductguide.com/blog/?p=211 AgennixAgennix Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally Agennix AG announced that the next stage of the FORTIS-M trial has begun, with the first patient being dosed in Europe. FORTIS-M is a Phase 3 registration trial evaluating oral talactoferrin versus placebo in advanced non-small cell lung cancer (NSCLC) in patients whose disease has progressed following two or more prior therapies. The trial is expected to enroll approximately 720 patients.

For the full story, Click Here

]]> http://www.oncologyproductguide.com/blog/2010/01/21/agennix-expands-talactoferrin-phase-3-fortis-m-registration-trial-globally/feed/ 0